IDH2 and central nervous system cancer: Thus, ∼15 μMr-2HG was found in the cerebrospinal fluid (CSF) of breast cancer patients after surgery, similar to patients with lung cancer (7), which may even be comparable to some patients with glioma bearing IDH mutations (14.5–25.5 μMr-2HG in CSF) (7).